Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 1 49-1, 2004, Pages

  Wallace, John L ^a   Zamuner, Stella R ^a   McKnight, Webb ^a   Dicay, Michael ^a   Mencarelli, Andrea ^b   Del Soldato, Piero ^c   Fiorucci, Stefano ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF PERUGIA   (Italy)

^c NicOx SA   (France)

Author keywords

Cyclooxygenase 2; Lipoxin; Neutrophil; Nitric oxide; Ulcer

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; LIPOXIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SAFETY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH MUCOSA INJURY;

EID: 0347358001     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00295.2003     Document Type: Article

References (30)

1. Asako H, Kubes P, Wallace JL, Wolf RE, and Granger DN. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 103: 146-152, 1992.
2. 4 ELISA. J Pharmacol Exp Ther 287: 779-790, 1998.
3. Claria J and Serhan CN. Aspirin triggers previously unrecognized bioactive eicosanoids in human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92: 9475-9479, 1995.
4. Davies NM, Sharkey KA, Asfaha S, MacNaughton WK, and Wallace JL. Aspirin induces a rapid up-regulation of cyclooxygenase-2 expression in the rat stomach. Aliment Pharmacol Ther 11, 1101-1108, 1997.
5. Fiorucci S, Antonelli E, Santucci L, Morelli O, Miglietti M, Federici B, Mannucci R, Del Soldato P, and Morelli A. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology 116: 1089-1106, 1999.
6. Fiorucci S, Distrutti E, Menezes de Lima O, Romano M, Mencarelli A, Barbanti M, Palazzini E, Morelli A, and Wallace JL. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J 17: 1171-1173, 2003.
7. Fiorucci S, Mencarelli A, Meneguzzi A, Lechi A, Morelli A, del Soldato P, and Minuz P. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. Circulation 106: 3120-3125, 2002.
8. 1 in TNBS-induced colitis. Immunity 17: 769-780, 2002.
9. 4 increases gastric resistance to aspirin-induced damage. Gastroenterology 123: 1598-1606, 2002.
10. Fiorucci S, Santucci L, Gresele P, Faccino RM, Del Soldato P, and Morelli A. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 124: 600-607, 2003.
11. Fiorucci S, Santucci L, Mencarelli A, Distrutti E, Fanini C, Federici B, Sardina M, Santus G, Wallace JL, Del Soldato P, and Morelli A. Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by NO-aspirin (NCX-4016): a randomized, parallel group, blind-observer endoscopic study. Evidence for a protective role of NO in the gastrointestinal mucosa (Abstract), Gastroenterology 124: A93, 2003.
12. Gretzer B, Ehrlich K, Maricic N, Lambrecht N, Respondek M, and Peskar BM. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br J Pharmacol 123: 927-935, 1998.
13. Gretzer B, Maricic N, Respondek M, Schuligoi R, and Peskar BM. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 132: 1565-1573, 2001.
14. Maricic N, Ehrlich K, Gretzer B, Schuligoi R, Respondek M, and Peskar BM. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach. Br J Pharmacol 128: 1659-1666, 1999.
15. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, and Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803, 1989.
16. Reuter BK, Asfaha S, Buret A, Sharkey KA, and Wallace JL. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 98: 2076-2085, 1996.
17. Robert A, Leung FW, Kaiser DG, and Guth PH. Potentiation of aspirin-induced gastric lesions by exposure to cold in rats. Role of acid secretion, mucosal blood flow, and gastric mucosal prostanoid content. Gastroenterology 97: 1147-1158, 1989.
18. Serhan CN and Oliw E. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 107: 1481-1489, 2001.
19. Souza MHLP, Menezes de Lima O, Zamuner SR, Fiorucci S, and Wallace JL. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. Am J Physiol Gastrointest Liver Physiol 285: G54-G61, 2003.
20. Tanaka A, Araki H, Komoike Y, Hase S, and Takeuchi K. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris 95: 21-27, 2001.
21. Turesin F, Del Soldato P, and Wallace JL. Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of prednisolone in the rat. Br J Pharmacol 139: 966-972, 2003.
22. Wallace JL, Arfors KE, and McKnight GW. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 100: 878-883, 1991.
23. Wallace JL and Cohen MM. Gastric mucosal protection with chronic mild restraint: role of endogenous prostaglandins. Am J Physiol Gastrointest Liver Physiol 247: G127-G132, 1984.
24. Wallace JL, Ignarro LJ, and Fiorucci S. Potential cardioprotective actions of NO-releasing aspirin. Nat Rev Drug Discov 1: 375-382, 2002.
25. Wallace JL, Keenan CM, and Granger DN. Gastric ulceration induced by non-steroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol Gastrointest Liver Physiol 259: G462-G467, 1990.
26. Wallace JL, McKnight W, Del Soldato P, Baydoun AR, and Cirino G. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest 96: 2711-2718, 1995.
27. Wallace JL, McKnight W, Miyasaka M, Tamatani T, Paulson J, Anderson DC, Granger DN, and Kubes P. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol 265: G993-G998, 1993.
28. Wallace JL, McKnight W, Reuter BK, and Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119: 706-714, 2000.
29. Wallace JL, McKnight W, Wilson TL, Del Soldato P, and Cirino G. Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils. Am J Physiol Gastrointest Liver Physiol 273: G1246-G1251, 1997.
30. Wallace JL, Muscara MN, McKnight W, Dicay M, Del Soldato P, and Cirino G. In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016. Thromb Res 93: 43-50, 1999.